Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Medical Oncology Hematology Consultants | Researchclopedia

Back to institutions

Medical Oncology Hematology Consultants

Newark, Delawarehealthcare

297

Works

11,593

Citations

50

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Economic and Financial Impacts of Cancer Cancer Immunotherapy and Biomarkers

Top Researchers

Everett E. Vokes University of Illinois Chicago

1,235 works79,178 citationsh-index: 119

Recent Research

Real-world time to next treatment in metastatic urothelial cancer patients: Enfortumab vedotin and pembrolizumab vs chemotherapy as first-line treatment.

Dhaval Shah,Deepak Kilari,et al.

20260 citations

Cancer Genomics and Diagnostics

Prostate Cancer Treatment and Research

Health Systems, Economic Evaluations, Quality of Life

Colorectal Cancer Treatments and Studies

Lung Cancer Research Studies

Chronic Lymphocytic Leukemia Research

Pancreatic and Hepatic Oncology Research

Lung Cancer Diagnosis and Treatment

Cancer survivorship and care

R. Graham Barr Youngstown State University

1,167 works56,325 citationsh-index: 124

Wilson H. Miller Jewish General Hospital

612 works44,409 citationsh-index: 80

Nicholas J. Petrelli Christiana Care Health System

506 works41,946 citationsh-index: 77

Joseph Bennett Sinai Hospital

86 works36,912 citationsh-index: 39

Amy Chadburn Cornell University

516 works34,522 citationsh-index: 83

Real-world ARPI utilization patterns and outcomes in metastatic castration-sensitive prostate cancer.

Manish Kohli,Jonathan D. Tward,et al.

20260 citations

Updated efficacy results from the phase 1 study of gotistobart (BNT316/ONC-392) in combination with lutetium Lu 177 vipivotide tetraxetan (Lu 177) in patients with metastatic castration-resistant prostate cancer (mCRPC).

David R. Wise,Tian Zhang,et al.

20260 citations

Clinical outcomes in the real-world utilization of 177Lu-PSMA 617 in metastatic castrate-resistant prostate cancer.

Manish Kohli,Jonathan D. Tward,et al.

20260 citations

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102).

Yu-Wei Chen,Olivia Bobek,et al.

20260 citations

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

Audrey E. Kam,Fengmin Zhao,et al.

20250 citations